ECA
BSX icon

Elevated Capital Advisors’s Boston Scientific BSX Stock Holding History

Elevated Capital Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$811 Hold
19
– – ﹤0.01% 760
2026
Q1 		$1.19K Hold
19
– – ﹤0.01% 715
2025
Q4 		$1.81K Buy
+19
New +$1.86K ﹤0.01% 638

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Elevated Capital Advisors's BSX Position: Q2 2026 in Review

Elevated Capital Advisors held its Boston Scientific (BSX) position steady in Q2 2026 at 19 shares worth $811. The position accounts for ﹤0.01% of the portfolio, ranked #760.

Elevated Capital Advisors first reported a position in BSX in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.81K in Q4 2025. 1,474 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Elevated Capital Advisors held 19 shares of Boston Scientific worth $811 as of Q2 2026.
  • Elevated Capital Advisors left its Boston Scientific share count unchanged in Q2 2026.
  • Boston Scientific made up ﹤0.01% of Elevated Capital Advisors's portfolio in Q2 2026, its #760 holding.
  • Elevated Capital Advisors first reported a position in Boston Scientific in Q4 2025 and has held it in 3 quarters since.
  • Elevated Capital Advisors's Boston Scientific position peaked at $1.81K in Q4 2025.
  • 1,474 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Elevated Capital Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.